mt logoMyToken
ETH Gas
EN

Moderna Stock Falls Over 8% Premarket as Citi Says $200 Price Would Require $26 Billion in Cancer Sales

Favoritecollect
Shareshare

Moderna Stock Falls Over 8% Premarket as Citi Says $200 Price Would Require $26 Billion in Cancer Sales

Moderna Inc. (NASDAQ: MRNA) shares fell 8.57% to $186.03 in Wednesday premarket trading after Citi downgraded the stock.

Visit Website

Disclaimer: This article is copyrighted by the original author and does not represent MyToken’s views and positions. If you have any questions regarding content or copyright, please contact us.(www.mytokencap.com)contact
More exciting content is available on
X(https://x.com/MyTokencap)
or join the community to learn more:MyToken-English Telegram Group
(https://t.me/mytokenGroup)